7-138802936-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001085429.2(TMEM213):c.191G>A(p.Arg64His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000186 in 1,605,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001085429.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM213 | NM_001085429.2 | c.191G>A | p.Arg64His | missense_variant | 3/3 | ENST00000442682.7 | NP_001078898.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM213 | ENST00000442682.7 | c.191G>A | p.Arg64His | missense_variant | 3/3 | 1 | NM_001085429.2 | ENSP00000390407 | P4 | |
TMEM213 | ENST00000397602.7 | c.188G>A | p.Arg63His | missense_variant | 3/3 | 1 | ENSP00000380727 | A2 | ||
TMEM213 | ENST00000458494.1 | c.119G>A | p.Arg40His | missense_variant | 2/2 | 4 | ENSP00000393891 | |||
TMEM213 | ENST00000413208.1 | c.154+1538G>A | intron_variant | 3 | ENSP00000401570 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000711 AC: 17AN: 239110Hom.: 0 AF XY: 0.0000769 AC XY: 10AN XY: 129962
GnomAD4 exome AF: 0.000192 AC: 279AN: 1453352Hom.: 0 Cov.: 31 AF XY: 0.000191 AC XY: 138AN XY: 722728
GnomAD4 genome AF: 0.000131 AC: 20AN: 152354Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74496
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at